Cargando…
Immunohistochemical detection of the chondroitin sulfate proteoglycan 4 protein in primary and metastatic melanoma
Treatment of malignant melanoma, the most aggressive form of skin cancer, continues to be a major challenge for clinicians. New targeted therapies with kinase inhibitors or drugs which modify the immune response are often accompanied by the development of resistance or severe side effects. In this c...
Autores principales: | Grossauer, Anna, Uranowska, Karolina, Kitzwögerer, Melitta, Mostegel, Margit, Breiteneder, Heimo, Hafner, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407859/ https://www.ncbi.nlm.nih.gov/pubmed/37559576 http://dx.doi.org/10.3892/ol.2023.13968 |
Ejemplares similares
-
Expression of chondroitin sulfate proteoglycan 4 (CSPG4) in melanoma cells is downregulated upon inhibition of BRAF
por: Uranowska, Karolina, et al.
Publicado: (2021) -
A chondroitin sulfate proteoglycan 4-specific monoclonal antibody inhibits melanoma cell invasion in a spheroid model
por: Uranowska, Karolina, et al.
Publicado: (2021) -
Anti-chondroitin sulfate proteoglycan 4-specific antibodies modify the effects of vemurafenib on melanoma cells differentially in normoxia and hypoxia
por: PUCCIARELLI, DANIELA, et al.
Publicado: (2015) -
An Infrared Absorbance Sensor for the Detection of Melanoma in Skin Biopsies
por: Fioravanti, Valeria, et al.
Publicado: (2016) -
Melanoma chondroitin sulfate proteoglycan enhances FAK and ERK activation by distinct mechanisms
por: Yang, Jianbo, et al.
Publicado: (2004)